Anticancer effects of ginsenoside Rg1, cinnamic acid, and tanshinone IIA in osteosarcoma MG-63 cells: Nuclear matrix downregulation and cytoplasmic trafficking of nucleophosmin

International Journal of Biochemistry and Cell Biology

Volumn 40, Issue 9, 2008, Pages 1918-1929

  Li, Qi Fu ^a   Shi, Song Lin ^a   Liu, Qing Rong ^b   Tang, Jian ^a   Song, Jianye ^a   Liang, Ying ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Ginsenoside; Human osteosarcoma; Induced differentiation; Nuclear matrix; Nucleophosmin

Indexed keywords

CINNAMIC ACID; GINSENOSIDE RG 1; NUCLEOPHOSMIN; PROTEIN P53; RETINOBLASTOMA PROTEIN; RIBOSOME RNA; TANSHINONE; TANSHINONE IIA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG TARGETING; GINSENG; HUMAN; HUMAN CELL; IMMUNOGOLD ELECTRON MICROSCOPY; ONCOGENE; ONCOGENE C FOS; ONCOGENE C MYC; OSTEOSARCOMA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; SALVIA MILTIORRHIZA; SCROPHULARIACEAE; TUMOR SUPPRESSOR GENE;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CATTLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CINNAMATES; CYTOPLASM; DATABASES, FACTUAL; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GINSENOSIDES; MITOCHONDRIA; NUCLEAR MATRIX-ASSOCIATED PROTEINS; NUCLEAR PROTEINS; ONCOGENES; PHENANTHRENES; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-MYC; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR SUPPRESSOR PROTEIN P53;

PANAX GINSENG; SALVIA;

EID: 45249091464     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2008.01.031     Document Type: Article

References (39)

1. Alsayed Y., Uddin S., Mahmud N., Lekmine F., Kalvakolanu D.V., Minucci S., et al. Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to all-trans-retinoic acid. Journal of Biological Chemistry 276 (2001) 4012-4019
2. Bertwistle D., Sugimoto M., and Sherr C.J. Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23. Molecular and Cellular Biology 24 (2004) 985-996
3. Capco D.G., Wan K.M., and Penman S. The nuclear matrix: Three-dimensional architecture and protein composition. Cell 29 (1982) 847-858
4. Chan P.K., and Chan F.Y. A study of correlation between NPM-translocation and apoptosis in cells induced by daunomycin. Biochemical Pharmacology 57 (1999) 1265-1273
5. Chan P.K., Qi Y., Amley J., and Koller C.A. Quantitation of the nucleophosmin/B23-translocation using imaging analysis. Cancer Letters 100 (1996) 191-197
6. Chou Y.H., and Yung B.Y. Cell cycle phase-dependent changes of localization and oligomerization states of nucleophosmin/B23. Biochemical and Biophysical Research Communications 217 (1995) 313-325
7. Colombo E., Marine J.C., Danovi D., Falini B., and Pelicci P.G. Nucleophosmin regulates the stability and transcriptional activity of p53. Nature Cell Biology 4 (2002) 529-533
8. Colombo E., Bonetti P., Lazzerini Denchi E., Martinelli P., Zamponi R., Marine J.C., et al. Nucleophosmin is required for DNA integrity and p19Arf protein stability. Molecular and Cellular Biology 25 (2005) 8874-8886
9. Dhar S.K., Lynn B.C., Daosukho C., and St Clair D.K. Identification of nucleophosmin as an NF-kappa B co-activator for the induction of the human SOD2 gene. Journal of Biological Chemistry 279 (2004) 28209-28219
10. Falini B., Mecucci C., Tiacci E., Alcalay M., Rosati R., Pasqualucci L., et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. New England Journal of Medicine 352 (2005) 254-266
11. Falini B., Nicoletti I., Martelli M.F., and Mecucci C. Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc(+) AML): Biologic and clinical features. Blood 109 (2007) 874-885
12. Feuerstein N., and Mond J.J. "Numatrin," a nuclear matrix protein associated with induction of proliferation in B lymphocytes. Journal of Cellular Biochemistry 262 (1987) 11389-11397
13. Feuerstein N., Spiegel S., and Mond J.J. The nuclear matrix protein, numatrin (B23), is associated with growth factor-induced mitogenesis in Swiss 3T3 fibroblasts and with T lymphocyte proliferation stimulated by lectins and anti-T cell antigen receptor antibody. The Journal of Cell Biology 107 (1988) 1629-1642
14. Gao J.G., Han Y.R., Jiao R.J., and Zhai Z.H. The intermediate filament-lamina-nuclear matrix system of ES-M13 cells. Shi Yan Sheng Wu Xue Bao 27 (1994) 463-475
15. Grisendi S., Bernardi R., Rossi M., Cheng K., Khandker L., Manova K., et al. Role of nucleophosmin in embryonic development and tumorigenesis. Nature 437 (2005) 147-153
16. Guo Q.M., Malek R.L., Kim S., Chiao C., He M., Ruffy M., et al. Identification of c-Myc responsive genes using rat cDNA microarray. Cancer Research 60 (2000) 5922-5928
17. Helms S. Cancer prevention and therapeutics: Panax ginseng. Alternative Medicine Review 9 (2004) 259-274
18. Korgaonkar C., Hagen J., Tompkins V., Frazier A.A., Allamargot C., Quelle F.W., et al. Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function. Molecular and Cellular Biology 25 (2005) 1258-1271
19. Kurki S., Peltonen K., Latonen L., Kiviharju T.M., Ojala P.M., Meek D., et al. Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell 5 (2004) 465-475
20. Lambert B., and Buckle M. Characterisation of the interface between nucleophosmin (NPM) and p53: Potential role in p53 stabilisation. FEBS Letters 580 (2006) 345-350
21. Li J., Zhang X., Sejas D.P., and Pang Q. Negative regulation of p53 by nucleophosmin antagonizes stress-induced apoptosis in human normal and malignant hematopoietic cells. Leukemia Research 29 (2005) 1415-1423
22. Lin C.Y., Liang Y.C., and Yung B.Y.M. Nucleophosmin/B23 regulates transcriptional activation of E2F1 via modulating the promoter binding of NF-kappa B, E2F1 and pRB. Cellular Signalling 18 (2006) 2041-2048
23. Michishita E., Kurahashi T., Suzuki T., Fukuda M., Fujii M., Hirano H., et al. Changes in nuclear matrix proteins during the senescence-like phenomenon induced by 5-chlorodeoxyuridine in HeLa cells. Experimental Gerontology 37 (2002) 885-890
24. Morris S.W., Kirstein M.N., Valentine M.B., Dittmer K.G., Shapiro D.N., Saltman D.L., et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263 (1994) 1281-1284
25. Nickerson J.A., Krockmalnic G., Wan K.M., and Penman S. The nuclear matrix revealed by eluting chromatin from a cross-linked nucleus. Proceedings of the National Academy of Sciences of the United States of America 94 (1997) 4446-4450
26. Okuda M., Horn H.F., Tarapore P., Tokuyama Y., Smulian A.G., Chan P.K., et al. Nucleophosmin/B23 is a target of CDK2/Cyclin E in centrosome duplication. Cell 103 (2000) 127-140
27. Okuwaki M., Matsumoto K., Tsujimoto M., and Nagata K. Function of nucleophosmin/B23, a nucleolar acidic protein, as a histone chaperone. FEBS Letters 506 (2001) 272-276
28. Raimondi S.C., Dube I.D., Valentine M.B., Mirro Jr. J., Watt H.J., Larson R.A., et al. Clinicopathologic manifestations and breakpoints of the t(3;5) in patients with acute nonlymphocytic leukemia. Leukemia 3 (1989) 42-47
29. Redner R.L. Variations on a theme: The alternate translocations in APL. Leukemia 16 (2002) 1927-1932
30. Savkur R.S., and Olson M.O.J. Preferential cleavage in pre-ribosomal RNA by protein B23 endoribonuclease. Nucleic Acids Research 26 (1998) 4508-4515
31. Sparreboom A., Cox M.C., Acharya M.R., and Figg W.D. Herbal remedies in the United States: Potential adverse interactions with anticancer agents. Journal of Clinical Oncology 22 (2004) 2489-2503
32. Subong E.N.P., Shue M.J., Epstein J.I., Briggman J.V., Chan P.K., and Partin A.W. Monoclonal antibody to prostate cancer nuclear matrix protein (PRO: 4-216) recognizes nucleophosmin/B23. Prostate 39 (1999) 298-304
33. Szebeni A., and Olson M.O. Nucleolar protein B23 has molecular chaperone activities. Protein Science 8 (1999) 905-912
34. Tang J., Niu J.W., Xu D., Li Z.X., Li Q.F., and Chen J.A. Alteration of nuclear matrix-intermediate filament system and differential expression of nuclear matrix proteins during human hepatocarcinoma cell differentiation. World Journal of Gastroenterology 13 (2007) 2791-2797
35. Yun T.K. Panax ginseng-a non-organ-specific cancer preventive?. Lancet Oncology 2 (2001) 49-55
36. Yun J.P., Chew E.C., Liew C.T., Chan J.Y.H., Jin M.L., Ding M.X., et al. Nucleophosmin/B23 is a proliferate shuttle protein associated with nuclear matrix. Journal of Cellular Biochemistry 90 (2003) 1140-1148
37. Yung B.Y. Oncogenic role of nucleophosmin/B23. Chang Gung Medical Journal 30 (2007) 285-293
38. Yung B.Y., Yang Y.H., and Bor A.M. Nucleolar protein B23 translocation after deferoxamine treatment in a human leukemia cell line. International Journal of Cancer 48 (1991) 779-784
39. Zeller K.I., Haggerty T.J., Barrett J.F., Guo Q.B., Wonsey D.R., and Dang C.V. Characterization of nucleophosmin (B23) as a Myc target by scanning chromatin immunoprecipitation. Journal of Biological Chemistry 276 (2001) 48285-48291